Brooks Sports

1920 ad for Bruxshu Gymnasium Shoes

Brooks Sports, Inc. was founded in 1914 by John Brooks Goldenberg, following his purchase of the Quaker Shoe Company, a manufacturer of bathing shoes and ballet slippers.[10] Based in Philadelphia, it operated as a partnership between John Goldenberg and his brothers, Michael and Frank. By 1920, Quaker Shoes had been renamed Brooks Shoe Manufacturing Co., Inc., and its shoes were sold under the brand name Bruxshu. In addition to bathing shoes and ballet slippers, it sold a gymnasium shoe, Ironclad Gyms.[12] The company's innovations included the 1938 introduction of orthopedic shoes for children, Pedicraft,[lower-alpha 1] and rubber brakes for roller skates (then known as "quick stops"), patented in 1944.[14]

In 1938, the Goldenbergs bought the Carmen Shoe Manufacturing Company in Hanover, Pennsylvania. Until 1957 a better grade leather was purchased, cut, stitched and fit in Philadelphia, while the same procedure in Hanover used lower grade materials. Both shoes were sold in Philadelphia under the Brooks name, and ranged from inexpensive to high-priced.[15]

In 1956, after a series of operational changes, John notified his brother that he would not renew their partnership agreement, and Michael discussed expanding Carmen with his nephew, Frank's son Barton. In 1957, following the dissolution of the partnership, the existence of Brooks Shoe Manufacturing Company was terminated, and Michael and Barton each acquired 50% of Carmen. In 1958, Michael purchased Barton's interest in the company, and as the sole owner, he renamed Carmen the Brooks Manufacturing Company.[15]

In 1975, Brooks worked with elite runners, including Marty Liquori, a former Olympian, to design a running shoe. The collaboration produced the Villanova, Brooks's first high-performance running shoe.[16] It was the first running shoe to use EVA, an air-infused foam that was quickly adopted by other athletic brands. Brooks followed the Villanova with the Vantage, a running shoe constructed with a wedge to address overpronation. In 1977, based on newly developed measurements of cushioning, flexibility, and durability, the Vantage was ranked at #1 in the annual Runner's World running guide.[17] Runners embraced Brooks' technology, and the demand "exploded". Towards the end of the decade Brooks was among the top three selling brands in the US.[18] The Vanguard was another running shoe which appeared in this decade.

In 1980, as a result of production issues with Brooks's manufacturing facility in Puerto Rico, defective shoes began to arrive at sporting goods stores. Nearly 30 percent of the shoes were returned, and Brooks scrapped 50,000 pairs. The company filed for Chapter 11 bankruptcy, and was purchased at auction by footwear manufacturer Wolverine World Wide in 1981.[4][18]

In 1982, stability became the top priority for runners, and Brooks introduced the Chariot, a medial post shoe that featured an angled wedge of harder-density foam in the midsole. Thicker on the inside of the shoe and tapered toward the outside, the Chariot represented a "sea change" in running-shoe design.[17] In 1987, with Brooks for Women, it launched an anatomically adjusted line of shoes designed for women.[10]

Brooks Adrenaline GTS 18 (2017)

In 1992, Brooks launched the Beast, a motion control shoe that integrated diagonal rollbar technology. In 1994, the Adrenaline GTS—an abbreviation for go-to shoe—was released. With a firmer midsole density, the Adrenaline GTS was built on a semi-curve, an accommodation for runners with a high arch and wide forefoot. The Beast became a best seller, and the Adrenaline GTS went on to become one of the best-selling running shoes of all time.[5][19]

Wolverine moved Brooks away from the niche running market to a generalist athletic brand. The "class to mass" strategy was unsuccessful, and Brooks was sold to Norwegian private equity company The Rokke Group for $21 million in 1993. Brooks moved to Rokke's Seattle location following its acquisition. In 1998, Rokke sold a majority interest in Brooks to J.H. Whitney & Co., a Connecticut private equity firm.[20]

Brooks introduced a full-line of technical running and fitness apparel for women and men in the spring of 1997. It also expanded into the walking category with the introduction of performance walking shoes.[21]

Brooks's Run Happy tag line first appeared in print advertising in 1999.[4] Rather than depicting running as a grueling pursuit, as competitive brands did, Run Happy was based on the idea that runners love running, and suggested that Brooks products allowed "runners to have the running experience they were looking for".[22][16]

In 2001, Jim Weber, a former Brooks board member, was named president and CEO of the company. At the time, the company's market share was low, and bankruptcy had again become a concern. Weber cut lower-priced footwear from the Brooks product line, added an on-site lab and staff engineers, and focused the company on technical-performance running shoes.[23] As the brand was rebuilt, its annual revenue fell to $20 million. Three years later, it was $69 million.[20]

Brooks was acquired by Russell Athletic in 2004. In 2006, Russell was purchased by Fruit of the Loom and Brooks became a subsidiary of Fruit of the Loom's parent company, Berkshire Hathaway. It became an independent subsidiary of Berkshire Hathaway in 2011.[20]

In the mid-2000s, Brooks introduced High Performance Green Rubber, a material it developed for outsoles that used sand rather than petroleum.[24] It subsequently developed BioMoGo, the first biodegradable mid-sole for running shoes.[11] It used a non-toxic, natural additive that increased the rate of biodegradation by encouraging microbes in the soil to break the material down into nutrients that could be used by plants and animals, biodegrading approximately 20 times faster than traditional soles. By using BioMoGo, Brooks estimated that it would cut more than 30 million pounds of landfill waste over a 20-year period. The BioMoGo technology was open source.[25]

Brooks DNA (and later Super DNA) was released in 2013. It provided customized cushioning, and adapted to the user's gender, weight and pace. Engineered from non-Newtonian liquid, it was another of Brooks's technological "firsts".[26]

In 2011, Brooks became the leading running shoe in the specialty market. On its 100-year anniversary, with a 29% market share, Brooks revenue hit $500 million. Weber stated that based on the company's year-over-year growth, investments from Berkshire Hathaway and the support of its CEO, Warren Buffett,[20] Brooks would become a billion dollar brand.[1][2]

The Brooks Heritage Collection was launched in 2016, returning the Vanguard, the Chariot, and the Beast to the market. Only the technology was updated; the details of the original shoes, including the colorways, were replicated.[27]

Brooks introduced the first customized performance running shoe based on personal biomechanics in the United States in December 2017. An in-store station that combines 3D foot scanning with gait analysis and pressure mapping, it was developed in partnership with HP and Superfeet.[28]

In 2017, Brooks shoes were named Best Running Shoe (The Glycerine and the Launch, Sports Illustrated);[8][29] Editor's Top Choice (The Adrenaline GTS 18, Runner's World);[9] and Ten Best Running Shoes (The Levitate, Men's Fitness).[30]

Shortly after, Brooks developed the DNA Flash—their first nitrogen-injected midsole technology—and applied it to silhouettes such as the Hyperion Tempo as well as a few easy everyday running shoes. The brand worked with nitrogen injection for about three and a half years before releasing its DNA Loft V3 nitrogen-injected foam, which was introduced in the Aurora BL sneaker.[31]

• Hansons-Brooks
• Brooks Beasts Track Club
• Brooks Mavericks
• Brooks Run Happy Team